15-Deoxy-Δ12,14-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-γ-independent mechanism

This publication has 24 references indexed in Scilit:

• 15‐Deoxy‐Δ^12,14‐PGJ₂, but not troglitazone, modulates IL‐1β effects in human chondrocytes by inhibiting NF‐κB and AP‐1 activation pathways
  FEBS Letters, 2001
• Feedback Control of the Arachidonate Cascade in Rheumatoid Synoviocytes by 15-deoxy-Δ12,14-Prostaglandin J2
  Biochemical and Biophysical Research Communications, 2001
• Cyclooxygenase-2 Expression in Lipopolysaccharide-Stimulated Human Monocytes Is Modulated by Cyclic AMP, Prostaglandin E2, and Nonsteroidal Anti-inflammatory Drugs
  Biochemical and Biophysical Research Communications, 2000
• Salicylate Metabolites Inhibit Cyclooxygenase-2-Dependent Prostaglandin E2 Synthesis in Murine Macrophages
  Biochemical and Biophysical Research Communications, 2000
• Role of the peroxisome proliferator‐activated receptor‐γ (PPAR‐γ) and its natural ligand 15‐deoxy‐Δ^12,14‐prostaglandin J₂in the regulation of microglial functions
  European Journal of Neuroscience, 2000
• Prostaglandin E2 Upregulates Cyclooxygenase-2 Expression in Lipopolysaccharide-Stimulated RAW 264.7 Macrophages
  Biochemical and Biophysical Research Communications, 2000
• A Synthetic Antagonist for the Peroxisome Proliferator-activated Receptor γ Inhibits Adipocyte Differentiation
  Published by Elsevier ,2000
• Differential activation of adipogenesis by multiple PPAR isoforms.
  Genes & Development, 1996
• 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
  Cell, 1995
• Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
  Cell, 1994